MedImmune
Executive Summary
Announces $21 mil. private placement of new common stock to institutional investors, who are set to buy 1.12 mil. shares at $18.50 per share. The transaction, announced Aug. 13, was arranged by Vector Securities and is contingent on the effectiveness of a registration statement covering resale of the stock.